Drug manufacturers in India will soon be required to upload their product formulations and brand names on the government's portal
In order to safeguard patients, the Drug Technical Advisory Board (DTAB) proposed banning the production and marketing of distinct drugs under identical brand names
The latest order is in line with government's push for affordable medicines